기준가
$26.59
운용 규모
$11.7M
보수율
-
배당수익률
0.00%
베타
0.00
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +8.36% | +1.96% | +7.31% | +8.36% | - | - |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 2.90% |
| 2 | XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.21% |
| 3 | HSBA.L | HSBC Holdings PLC | 1.45% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.38% |
| 5 | AZN.L | AstraZeneca PLC | 1.37% |
| 6 | NOVN.SW | Novartis AG Registered Shares | 1.33% |
| 7 | SHEL.L | Shell PLC | 1.19% |
| 8 | SIE.DE | Siemens AG | 1.19% |
| 9 | 8306.T | Mitsubishi UFJ Financial Group Inc | 1.12% |
| 10 | NESN.SW | Nestle SA | 1.12% |
The fund is actively managed and seeks to pursue its investment objective while seeking to maintain a low tracking error to the MSCI EAFE Index. Under normal circumstances, the fund seeks to invest at least 80% of its net assets plus the amount of any borrowings for investment purposes in equity securities of foreign issuers and derivatives that provide investment exposure to such securities or to one or more market risk factors associated with such securities. The fund is non-diversified.
설정일: 2026-03-10